Re: Enzalutamide in Men with Nonmetastatic, Castration-resistant Prostate Cancer

被引：0
|
作者：
Mason, Malcolm [1 ]
机构：
[1] Cardiff Univ, Velindre Hosp, Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales
来源：
EUROPEAN UROLOGY | 2018年 / 74卷 / 06期
关键词：
CHEMOTHERAPY; SURVIVAL;
D O I：
10.1016/j.eururo.2018.08.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [41] Continuing enzalutamide with docetaxel in castration-resistant prostate cancer
    Shiota, Masaki
    LANCET ONCOLOGY, 2022, 23 (11): : 1345 - 1347
  • [42] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [43] Development of enzalutamide for metastatic castration-resistant prostate cancer
    Bhattacharya, Suman
    Hirmand, Mohammad
    Phung, De
    van Os, Steve
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 13 - 27
  • [44] The role of enzalutamide in the treatment of castration-resistant prostate cancer
    Rawlinson, Alex
    Mohammed, Aza
    Miller, Marek
    Kunkler, Roger
    FUTURE ONCOLOGY, 2012, 8 (09) : 1073 - 1081
  • [45] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [46] The ARAMIS trial: Why Darolutamide is better than apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer
    Tripathy, Sambit
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (03) : 293 - 294
  • [47] Re: Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer
    Kliment, Jan
    EUROPEAN UROLOGY, 2011, 59 (06) : 1066 - 1067
  • [48] Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate Cancer
    Walz, Jochen
    EUROPEAN UROLOGY, 2020, 78 (02) : 292 - 293
  • [49] Race Does Not Predict the Development of Metastases in Men With Nonmetastatic Castration-Resistant Prostate Cancer
    Whitney, Colette A.
    Howard, Lauren E.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Freedland, Stephen J.
    CANCER, 2016, 122 (24) : 3848 - 3855
  • [50] Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer
    Zhang, Tian
    Zhu, Jason
    George, Daniel J.
    Armstrong, Andrew J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 473 - 485
12345